FDA Adverse Event Injury Summary report: N

GRAFTYS BCP (510K NUMBER: K073064)

MDR report key: 3221882 · Received July 11, 2013

Report

Report Number
3006761298-2013-00001
Event Type
Injury
Date Received
July 11, 2013
Report Date
July 11, 2013
Manufacturer
GRAFTYS
Product Code
MQV
PMA / PMN Number
K073064
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

FOLLOWING AN INSPECTION AT OUR MFG SITE IN (B)(4) 2013, INSPECTOR HIGHLIGHTED A WEAKNESS IN OUR VIGILANCE PROCEDURES: WE SHOULD HAVE HAD NOTIFY TO COMPETENT AUTHORITIES SOME OF OUR COMPLAINTS. FOLLOWING THIS NON CONFORMITY, WE REVIEWED OUR VIGILANCE PROCEDURES AND REVIEWED ALL COMPLAINTS RECEIVED SO FAR (SINCE YR 2007). WE IDENTIFIED COMPLAINTS THAT NEEDED TO BE NOTIFIED AND WE DID. THAT EXPLAINS THE DELAY BETWEEN US BECOMING AWARE OF THE INCIDENT AND THE DATE WE NOTIFIED IT.

Description of Event or Problem · 1

ONE OF OUR DISTRIBUTOR IN (B)(6) RELATED US THE FOLLOWING SITUATION: A SURGEON FROM (B)(6) SAW DELAYED BONE HEALING AFTER "OSTEOMITIES" USING IMPLANT GRAFTYS BCP. HE RECOGNIZED SCLEROTIC BONE AND SEEMED TO BE AROUND IMPLANT. WE DONT' KNOW HOW MANY PTS WERE INVOLVED, NUMBER OF MEDICAL DEVICES USED, LOT NUMBER USED, IF THE ALLEGED INJURY RESULTED IN A IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO THE BODY STRUCTURE OR IF IT NECESSITATED MEDICAL OR SURGICAL INTERVENTION TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO THE BODY STRUCTURE. CONSIDERING THE LACK OF INFO IN OUR POSSESSION, WE CAN'T CONCLUDE ON A SERIOUS INJURY, EVEN THOUGH WE DECIDED TO TREAT THAT CASE AS A SERIOUS INJURY. (B)(4) COMPETENT AUTHORITY CONCERNED HAVE BEEN NOTIFIED OF THAT CASE. THE ONLY CONCLUSION WE HAVE IS THAT THIS SITUATION CAN HAPPEN DEPENDING OF THE SURGICAL TECHNIQUE USED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
320007 GRAFTYS BCP (510K NUMBER: K073064) GRAFTYS BCP MQV GRAFTYS NOT COMMUNICATED NOT COMMUNICATED

Patients

Seq Age Sex Outcome Treatment
1 NOT COMMUNICATED.